トヨダ ナガオキ
TOYODA NAGAOKI 豊田 長興 所属 関西医科大学 内科学第二講座 職種 診療教授 |
|
論文種別 | 原著(症例報告除く) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. |
掲載誌名 | 正式名:Atherosclerosis 略 称:Atherosclerosis ISSNコード:00219150 |
巻・号・頁 | 171(2),pp.211-218 |
著者・共著者 | Hasegawa T, Kosaki A, Kimura T, Matsubara H, Mori Y, Okigaki M, Masaki H, Toyoda N, Inoue-Shibata M, Kimura Y, Nishikawa M, Iwasaka T |
発行年月 | 2003/12 |
概要 | EN-RAGE is a ligand for the receptor for advanced glycation end products (RAGE) and may be involved in the development of diabetic macro- and micro-angiopathy. This study is designed to investigate the regulation of EN-RAGE gene expression in human macrophages. The amounts of EN-RAGE mRNA were measured in cultured human THP-1 macrophages after treatment with various stimuli known to modulate atherosclerosis. First, interleukin-6 (IL-6), a proinflammatory cytokine, increased the level of EN-RAGE mRNA by approximately 2-fold in a time- and a dose-dependent fashion. EN-RAGE protein was detected in the cultured medium and increased significantly by the addition of IL-6. The induction was abolished by pretreatment with the JAK kinase inhibitor and cycloheximide, but not with the MEK kinase inhibitor. Second, pioglitazone (PIO), a thiazolidinedione, decreased the level of EN-RAGE mRNA by approximately 25% of the basal in a time- and a dose-dependent fashion. Pioglitazone also inhibited the induction of EN-RAGE mRNA by IL-6. These results indicate the production of EN-RAGE is induced by IL-6 through de novo protein synthesis via the JAK-STAT kinase pathway and inhibited by the activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) in human macrophages. |
文献番号 | 14644389 |